Exagen Inc. Reports Third Quarter 2022 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Dow tick higher as investors weigh Mideast negotiations
- Oil falls after US-Iran talks signal easing supply risks
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
Exagen Inc. (XGN) Tops Q3 EPS by 29c
November 14, 2022 4:23 PM ESTExagen Inc. (NASDAQ: XGN) reported Q3 EPS of ($0.47), $0.29 better than the analyst estimate of ($0.76). Revenue for the quarter came in at $14.7 million versus the consensus estimate of $9.13 million.
GUIDANCE:
Exagen Inc. sees FY2022 revenue of $40-43 million, versus the consensus... More
